Ultrasound Guided Therapeutic Excisional Vacuum Assisted Biopsy in Breast Fibroadenomas

Bugdayci, Onur; Kaya, Hakan; Arıbal, Erkin

doi:10.5152/tjbh.2017.3038

Cited by 13 publications

(20 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a study by Buğdaycı et al, the incidence of recurrence was 15% and the recurrence was reported only after 6 months and some of them increased enough for re-excision on follow-up for 3 years. 18 Yao et al in their largest series of over 2,000 lesions reported a residual/recurrence rate of 5%. 21 There could be several factors for these varying results.…”

Section: Discussionmentioning

confidence: 96%

“…The complications reported in the literature have been hematoma formation, injury to skin or chest wall, vasovagal attacks, and infection. 6,[10][11][12][13][14][15][16][17][18][19][20] Post-procedure hematoma is the most common complication. In most of the patients, it can be controlled with adequate compression and does not require any intervention.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Vacuum-Assisted Excision, Scarless Solution for Fibroadenoma Breast—A Single-Center Experience

Rupa

Kushvaha

2021

Indian J Radiol Imaging

View full text Add to dashboard Cite

Background Fibroadenoma is one of the most common benign breast lesions that is frequently surgically excised in breast practice. Aim The aim of this study was to determine the efficacy and safety of ultrasound-guided (USG) vacuum-assisted excision biopsy (VAEB) of fibroadenoma. Settings and Design A retrospective observational study. Methods and Materials A total of 113 patients with 163 fibroadenomas who underwent USG-guided VAEB under local anesthesia with 7G and 10G probes using an Encor Enspire equipment were included in the study. The patients were followed up after 1, 6, and 12 months. The fibroadenomas up to 4 cm were excised as per the U.S. Food and Drug Administration-approved guidelines of the American Society of Surgeons for percutaneous removal of benign breast lesions. Results The percentage of complete excision rate was 98.8% and the most frequent complication encountered was hematoma including immediate and delayed accounting for 3.06%. There were no recurrent lesions in our study. Conclusion USG-guided VAEB of benign breast lumps can be a safe and effective alternative to surgical excision and had better patient satisfaction in terms of efficacy and cosmesis.

show abstract

Section: Discussionmentioning

confidence: 96%

Section: Discussionmentioning

confidence: 99%

Vacuum-Assisted Excision, Scarless Solution for Fibroadenoma Breast—A Single-Center Experience

Rupa

Kushvaha

2021

Indian J Radiol Imaging

View full text Add to dashboard Cite

show abstract

“…VABB could also be used in BI-RADS 3 lesions like fibroadenomas as a therapeutic procedure, in addition to the use for diagnostic purpose in malignant lesions (9,13). In our study, 84% (n= 42) of all lesions was diagnosed as benign, and residue was detected only in one of them during follow-up.…”

Section: Discussionmentioning

confidence: 61%

“…Ultrasound (US)-guided VABB, which can even be used in biopsies of calcifications, is a real-time biopsy method preferred in breast biopsies that does not involve ionizing radiation (2,7). Besides, it has been indicated that it is a method which can be preferred confidently in complete excision of benign lesions and can be tolerated by patients easily (8)(9)(10). In this manner, our aim in this study was to assess outcomes, complications, and follow-up results of US-guided VABB performed in lesions classified as category 4A and 4B in which malignancy rates are relatively low according to breast imaging-reporting and data system (BI-RADS).…”

Section: Introductionmentioning

confidence: 99%

Both a biopsy method and a therapeutic procedure in BI-RADS 4A and 4B lesions: Ultrasound-guided vacuumassisted breast biopsy

et al. 2020

View full text Add to dashboard Cite

Objective: This study aimed to evaluate outcomes, complications, and follow-up results of ultrasound-guided vacuum-assisted breast biopsy (UG-VABB) in BI-RADS 4 A and B lesions. Material and Methods: Between Agust 2014 to January 2018, fifty BI-RADS 4A and BI-RADS 4B lesions of 41 patients biopsied with 10G vacuum needle by a single radiologist were retrospectively evaluated. Results: All patients were females and mean age of the 41 patients was 50.12 ± 8.63. Of all lesions, 84% was benign, 6% was ADH, 4% was in-situ cancer, and 6% was diagnosed as malign. Follow-up duration after VABB was 0-51 months and mean was 20.92 months. Complications were as vasovagalinduced seizure in 3 patients (7.3%) and intramammary hematoma in 16 patients (39%). Hematoma was diagnosed in 3 patients (7.3%) at the 6 th month follow-up and it was resolved in all patients at the 12 th month follow-up. Higher breast density resulted in higher hematoma rates. There was no relationship between lesion BI-RADS subgroups, lesion size or sample number and hematoma development. During the follow-up, residue lesion in 1 (2.4%) patient and scar tissue in 2 (4.9%) patients was detected. Conclusion: US-guided VABB, with low complication rates and low scar development, is also a therapeutic excision method without remaining residue, which should be primarily preferred in smaller than 2 cm BI-RADS 4A and 4B lesions whose malignancy rates are relatively low. Hematoma, which is the most frequent complication, resorbed entirely in the 12 th month in all patients.

show abstract

“…It can be applied to lesions larger than 4.2 cm in diameter [18]. Fibroadenomas which are less than 3 cm are removed by ultrasound-guided vacuum-assisted excisional biopsy [19]. Breast conservation is usually feasible for fibroadenomas.…”

Section: Discussionmentioning

confidence: 99%

Dev juvenil fibroadenomun yönetiminde batwing mastopeksi yöntemi ile birlikte meme koruyucu cerrahi: 12 yaşinda kız olgu sunumu

Çıtgez

Baran

Yiğit

et al. 2020

Archives of Clinical and Experimental Medicine

View full text Add to dashboard Cite

Fibroadenomas are benign breast tumours consisting of epithelial and stromal components. Most of them are about 1 to 2 cm in size. It is defined as "giant" when the fibroadenoma is larger than 5cm, weighs more than 500 g or occupies for at least 80% of breast volume. It is usually encountered in patients of less than 20 years of age. Progressively growing mass and its large size cause a suspicion of malignancy. It presents as unilateral macromastia that causes breast asymmetry. Excellent cosmetic results cannot be obtained with simple excision in this situation. We aimed to present a case of a 12-year-old patient with a diagnosis of giant juvenile fibroadenoma. In this case, we performed surgical excision with Batwing mastopexy of the breast to achieve optimal symmetry with contralateral breast.

show abstract

Ultrasound Guided Therapeutic Excisional Vacuum Assisted Biopsy in Breast Fibroadenomas

Cited by 13 publications

References 14 publications

Vacuum-Assisted Excision, Scarless Solution for Fibroadenoma Breast—A Single-Center Experience

Vacuum-Assisted Excision, Scarless Solution for Fibroadenoma Breast—A Single-Center Experience

Both a biopsy method and a therapeutic procedure in BI-RADS 4A and 4B lesions: Ultrasound-guided vacuumassisted breast biopsy

Dev juvenil fibroadenomun yönetiminde batwing mastopeksi yöntemi ile birlikte meme koruyucu cerrahi: 12 yaşinda kız olgu sunumu

Contact Info

Product

Resources

About